Obesity in inflammatory bowel disease: A marker of less severe disease
It is still too early to draw definitive conclusions, but the numerous ongoing clinical trials, including the cardiovascular safety trial versus an active comparator (dulaglutide), the first of its kind, will provide us shortly with important confirmations
They differ mostly in provider type, pharmacy partner, and pricing tier
FIGURE 4 5.2.2 Protecting the blood-brain barrier The BBB is a complex structure consisting of cerebral microvascular endothelial cells, endothelial cell occluding, and claudin, intercellular zonula occludens-1 (ZO-1), astrocyte terminal foot, pericyte, and basement membrane (Mark and Davis, 2002
Therapies involving engineered antibodies that target specific molecules in the immune system may help by disrupting the autoimmune process
Another risk is that a LiPo that is experiencing thermal runaway may vent toxic gas, which can also explode if ignited